Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Steidl, Ulrich  [Clear All Filters]
2024
Piszczatowski RT, Buelow H, Steidl U. Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis. Blood. 2024.
Kao Y-R, Chen J, Kumari R, Ng A, Zintiridou A, Tatiparthy M, Ma Y, Aivalioti MM, Moulik D, Sundaravel S, et al. An iron rheostat controls hematopoietic stem cell fate. Cell Stem Cell. 2024.
2023
J Terrell R, Taylor SJ, Schneider AL, Lu Y, Vernon TN, Xhani S, Gumpper RH, Luo M, W Wilson D, Steidl U, et al. DNA selection by the master transcription factor PU.1. Cell Rep. 2023;42(7):112671.
Takeishi S, Marchand T, Koba WR, Borger DK, Xu C, Guha C, Bergman, iv A, Frenette PS, Gritsman K, Steidl U. Haematopoietic stem cell numbers are not solely determined by niche availability. bioRxiv. 2023.
Ames K, Kaur I, Shi Y, Tong MM, Sinclair T, Hemmati S, Glushakow-Smith SG, Tein E, Gurska L, Steidl U, et al. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells. Sci Adv. 2023;9(8):eade8222.
Ramachandra N, Gupta M, Schwartz L, Todorova T, Shastri A, Will B, Steidl U, Verma A. Role of IL8 in myeloid malignancies. Leuk Lymphoma. 2023:1-10.
2022
Chrysanthou S, Tang Q, Lee J, Taylor SJ, Zhao Y, Steidl U, Zheng D, Dawlaty MM. The DNA dioxygenase Tet1 regulates H3K27 modification and embryonic stem cell biology independent of its catalytic activity. Nucleic Acids Res. 2022.
2021
Schwenger E, Steidl U. An Evolutionary Approach to Clonally Complex Hematologic Disorders. Cancer Discov. 2021;2(3):201-215.
Taylor SJ, Sundaravel S, Steidl U. Exploiting a key transcriptional dependency: ZMYND8 and IRF8 in AML. Mol Cell. 2021;81(17):3445-3446.
Wheat JC, Steidl U. Gene Expression at a Single Molecule Level: Implications for MDS and AML. Blood. 2021.
Bowman TV, Jamieson C, Steidl U, E Stanley R, Gritsman K, Wagner D, Manwani D, Trumpp A, Suda T, Ito K, et al. Paul S. Frenette (1965-2021). Dev Cell. 2021.
Bowman TV, Jamieson C, Steidl U, E Stanley R, Gritsman K, Wagner D, Manwani D, Trumpp A, Suda T, Ito K, et al. Paul S. Frenette (1965-2021). Cell Stem Cell. 2021;28(10):1686-1689.
Bowman TV, Jamieson C, Steidl U, E Stanley R, Gritsman K, Wagner D, Manwani D, Trumpp A, Suda T, Ito K, et al. Paul S. Frenette (1965-2021). Cell. 2021;184(20):5073-5076.
2019
Sridharan A, Schinke CD, Georgiev G, Ferreira MDa Silva, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, et al. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias. Blood Adv. 2019;3(23):3962-3967.
Mattes K, Geugien M, Korthuis PM, Brouwers-Vos AZ, Fehrmann RSN, Todorova TI, Steidl U, Vellenga E, Schepers H. The transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells. Exp Hematol. 2019.
2018
Shastri A, Choudhary G, Teixeira M, Gordon-Mitchell S, Ramachandra N, Bernard L, Bhattacharyya S, Lopez R, Pradhan K, Giricz O, et al. Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells. J Clin Invest. 2018.
2016
Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CPeng, Techner J-M, Will B, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016.
Sato H, Wheat JC, Steidl U, Ito K. DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders. Front Oncol. 2016;6:187.
Carvajal LA, Steidl U. Eliminating Cancer Stem Cells in CML with Combination Transcriptional Therapy. Cell Stem Cell. 2016;19(1):6-8.
2015
Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015.
Verma A, Steidl U. A synthetic lethal approach targeting mutant isocitrate dehydrogenase in acute myeloid leukemia. Nat Med. 2015;21(2):113-114.
2012
Pandolfi A, Steidl U. HLX in AML: novel prognostic and therapeutic target. Oncotarget. 2012;3(10):1059-60.